Mar 25 |
Nkarta: NK Cell Therapy Advancement On Two Fronts
|
Mar 25 |
Why Nkarta Stock Just Boomeranged Following A Massive Dive On Friday
|
Mar 25 |
Nkarta announces pricing of stock offering to raise $240.1M
|
Mar 25 |
Nkarta Announces Pricing of $240 Million Underwritten Offering
|
Mar 23 |
Nkarta Inc (NKTX) Posts Full Year 2023 Financial Results: A Focus on NKX019 and Pipeline Realignment
|
Mar 22 |
Why Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line
|
Mar 22 |
These Analysts Revise Their Forecasts On Nkarta After Q4 Results
|
Mar 21 |
Nkarta GAAP EPS of -$0.57 beats by $0.03
|
Mar 21 |
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
|
Mar 19 |
3 Overlooked Stocks Ready to Capture the Market by Storm
|